Navigation Links
Data Show FluMist May Reduce Seasonal Influenza Burden Among,,,Children in School, Daycare Settings

hospitalizations through a review of medical utilization data on the vaccine recipients. The rates of events within the risk period (0 to 3 or 0 to 21 days after vaccination, depending on the event) were then compared to a corresponding reference control time period.

Abstracts for each of the studies above are available on the Pediatric Academic Societies' web site at www.pas-meeting.org/2007Toronto/default.htm.

About FluMist

FluMist is currently indicated for active immunization for the prevention of disease caused by influenza A and B viruses in healthy children and adolescents, 5 to 17 years of age, and healthy adults, 18 to 49 years of age. There are risks associated with all vaccines, including FluMist. As with any vaccine, FluMist does not protect 100 percent of individuals vaccinated and may not protect against viral strains not contained in the vaccine.

Under no circumstances should FluMist be administered as an injection (i.e., parenterally). FluMist is contraindicated in persons with hypersensitivity to any component of the vaccine, including eggs; in children and adolescents receiving aspirin therapy or aspirin-containing therapy; in individuals with a history of Guillain-Barre syndrome; and in individuals with known or suspected immune deficiency. The safety and efficacy of FluMist have not been established in pregnant women or for patients with chronic underlying medical conditions, including asthma or reactive airways disease; the vaccine should not be administered to these patients.

In randomized, placebo-controlled clinical trials of FluMist in its refrigerated and frozen formulations, the most common solicited adverse events in the indicated population (n=11,604) included runny nose/nasal congestion, sore throat, cough, irritability, headache, chills, vomiting, muscle ac
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
11. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
Post Your Comments:
(Date:2/26/2015)... 2015  BD Life Sciences, a segment of ... BDX ), a leading global medical technology company, ... enabling high-resolution biology, today announced that they will ... multiplexed cell isolation and single-cell gene expression analysis. ... BD FACS™ single-cell sorting instrumentation and software with ...
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank ... therapeutics for the treatment of virus infections, today ... has been appointed Vice President of Finance, a ... for financial and administrative activities, including financial planning ... to Douglas J. Jensen , President and ...
(Date:2/26/2015)... 26, 2015 Integrity Applications, Inc. (OTCQB: IGAP) ... model DF-F, a noninvasive  device that tracks blood glucose ... Ph.D., will head its new scientific advisory board that ... field of Diabetes research, monitoring and treatment. ... Chief Executive Officer and Head, Business Development of Profil ...
Breaking Medicine Technology:BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 2Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 3Integrity Applications Names Prof. Lutz Heinemann to Advisory Board 4
... Md., Nov. 9, 2010 The U.S. Food and ... computed tomography (CT) brain perfusion scans were accidently exposed ... used, the CT scanners did not malfunction. Instead, it ... resulted in these overdoses. However, the FDA has identified ...
... Colo., Nov. 9, 2010 Baxa Corporation , ... automate pharmacy operations, today introduced the ExactaMix 1200 ... hospital pharmacies in need of an automated approach to ... the market-proven Baxa ExactaMix Product Line and brings delivery ...
Cached Medicine Technology:FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions 2Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions 3Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions 4
(Date:2/27/2015)... Schenectady, New York (PRWEB) February 27, 2015 ... has been named one of the Best Companies to ... , “Transfinder recognizes the importance of creating a great ... a demanding – yet professionally fulfilling – environment. There’s ... doing great work together,” said Antonio Civitella, president and ...
(Date:2/27/2015)... NC (PRWEB) February 27, 2015 ... addressing the unique challenges faced by women with ... Leadership Institute. The Institute, which aims to develop ... nationwide, is scheduled for the weekend of April ... process, a rigorous selection of participants was made ...
(Date:2/27/2015)... NV (PRWEB) February 27, 2015 BaliniSports ... collaborating with the online fitness social platform FITMOO. The ... quality products and holistic philosophy behind BaliniSports. Users of ... in an intimate way and discover apparel that will ... brand that uses environmentally friendly and socially conscious methods ...
(Date:2/27/2015)... February 27, 2015 Several studies showing ... heart failure have made headline news recently. However, all ... research appearing in this month’s STEM CELLS Translational Medicine ... in treating children with congenital heart diseases that can ... by researchers at the Mayo Clinic in Rochester, Minn., ...
(Date:2/27/2015)... 27, 2015 The Obrella Insider ... in Florida " report today. To determine the ... U.S. Census Bureau survey, considering only Florida cities ... the survey. , The report visualizes compelling commuter ... commuting and a breakdown of commute durations. , ...
Breaking Medicine News(10 mins):Health News:Transfinder Named a Best Company to Work for in New York State 2Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2Health News:BaliniSports Announces Collaboration with FITMOO 2Health News:Study Shows Stem Cells Have Potential to Help Kids’ Hearts, Too 2Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2
... Focus is system that regulates blood pressure and fluid ... News) -- New research is shedding some light on ... cause miscarriage and death in pregnant women. , "Preeclampsia ... 10 percent of all pregnancies in the United States," ...
... (FA) is a rare and dangerous disease, new laboratory research ... shows it may lead researchers toward clues in more common ... a study published in the Sept. 11 issue of the ... proteins to DNA damage sites is controlled by replication in ...
... the biggest student drinking problems have so far failed to turn ... in the September issue of the Journal of Studies on ... students, alcohol habits showed little change over a dozen years. In ... two weeks; in 2005, 56 percent said the same. And although ...
... blind and visually impaired often rely on others to provide ... with this method is that it doesn,t give them the ... Lahav of Tel Aviv University,s School of Education and Porter ... to the blind, Dr. Lahav has invented a new software ...
... Administration,s (FDA) recent decision to approve the radioimmunotherapy (RIT) ... lymphoma (NHL). "This is welcome news for ... Ph.D., president of SNM and director of nuclear medicine ... "We,ve known for some time that RIT works extremely ...
... Television journalist Veronica ... and now directs her brother,s story to the White House , ... Los Angeles, CA (PRWeb) September 10, 2009 -- After ... brought the tale of her brother Eric,s tragic battle against health care red tape to ...
Cached Medicine News:Health News:Research Seeks Cause of Preeclampsia 2Health News:Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 2Health News:Heavy-drinking colleges showing no improvements 2Health News:Virtual maps for the blind 2Health News:Virtual maps for the blind 3Health News:SNM applauds FDA's decision to approve Zevalin 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 2Health News:Television Journalist Veronica De La Cruz Brings Her Brother's Story from L.A. to White House in Fight for Health Care Reform 3
... prints labels up to 8.5 ... It is ideal for wide ... chemical drum labels, primary metal ... banner-sized labels and pallet and ...
... Korchek Technologies CareChek Tx, which ... a software device for blood ... match the patient to the ... bedside before administering a transfusion.The ...
... Management system ensures your patients are receiving ... BloodTrack SafeTx uses the AutoPPI™ barcoded wristband ... collection to transfusion. SafeTx checks that the ... need for bedside paperwork and associated transcription ...
... The automated patient ID verification and laboratory ... the identity of the phlebotomist or nurse, the ... request. If proper verification is made, a bar ... the bedside. Its unique design simplifies and eliminates ...
Medicine Products: